Sign in
TCBP Stock Price, Chart, Stats & News
TC Biopharm (Holdings) Plc
Save
TC Biopharm (Holdings) Plc (TCBP) does not currently pay a dividend.
256,496
Market cap
–
Current P/E
–
Forward P/E
TCBP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 15.56% |
ROA | -66.13% |
ROE | -391.64% |
D/E | 0.67x |
Interest coverage ratio | – |
TCBP valuation
P/E | – |
P/S | – |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.02x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.06x |
About
Operating as a clinical-stage biopharmaceutical entity, TC Biopharm (Holdings) Plc is dedicated to pioneering immunotherapy solutions, leveraging its proprietary allogeneic gamma delta T cell platform. Its developmental portfolio includes OmnImmune, an unmodified cellular therapy aimed at acute myeloid leukemia, and ImmuniStim, another unmodified cellular therapy designed to combat COVID-19. The company was established in 2013 and is headquartered in Motherwell, United Kingdom.
Similar securities
Based on sector and market capitalization
Report issue